Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.
New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks
In a previous video, investigator Jessica Allegretti, MD, of the Crohn’s and Colitis Center at Brigham and Women’s Hospital in Boston, discussed the results from